Oral contraceptives in migraine therapy

Neurological Sciences

Volumn 32, Issue SUPPL. 1, 2011, Pages

  Allais, Gianni ^a   Gabellari, Ilaria Castagnoli ^a   De Lorenzo, Cristina ^a   Mana, Ornella ^a   Benedetto, Chiara ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Combined oral contraceptives; Headache; Hormonal treatment; Migraine; Oral contraceptive induced menstrual migraine; Progestogen only pill

Indexed keywords

DESOGESTREL; DIENOGEST; DROSPIRENONE; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GESTODENE; LEVONORGESTREL; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ARTICLE; DISEASE DURATION; DRUG INDUCED DISEASE; HEADACHE; HUMAN; LOW DRUG DOSE; MENSTRUAL MIGRAINE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; ORAL CONTRACEPTIVE INDUCED MENSTRUAL MIGRAINE; SYMPTOMATOLOGY;

CLINICAL TRIALS AS TOPIC; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; MIGRAINE DISORDERS;

EID: 79960142559     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0538-z     Document Type: Article

References (30)

1. Burkman RT, Collins JA, Shulman LP, Williams JK (2001) Current perspectives on oral contraceptive use. Am J Obstet Gynecol 185:S4-S12 (Pubitemid 32747855)
2. MacGregor EA, de Lignières B (2000) The place of combined oral contraceptives in contraception. Cephalalgia 20:157-163 (Pubitemid 32269503)
3. Loder EW, Buse DC, Golub JR (2005) Headache as a side effect of combination estrogen-progestin oral contraceptives: A systematic review. Am J Obstet Gynecol 193:636-649 (Pubitemid 41261456)
4. Mueller L (2000) Predictability of exogenous hormone effect in subgroups of migraineurs. Headache 40:189-193 (Pubitemid 30169882)
5. MacGregor EA, Igarashi H, Wilkinson M (1997) Headaches and hormones: Subjective versus objective assessment. Headache Q 8:126-136 (Pubitemid 27264171)
6. Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M (1995) Sex-hormone related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 15:140-144
7. Granella F, Sances G, Zanferrari C, Costa A, Martignoni GC (1993) Migraine without aura and reproductive life events: A clinical epidemiological study in 1300 women. Headache 33:385-389 (Pubitemid 23221829)
8. Massiou H, MacGregor EA (2000) Evolution and treatment of migraine with oral contraceptives. Cephalalgi 20:170-174 (Pubitemid 32269505)
9. MacGregor EA, Hackshaw A (2002) Prevention of migraine in the pill-free week of combined oral contraceptives using natural oestrogen supplements. J Fam Plann Reprod Health Care 28(1): 27-31 (Pubitemid 34150522)
10. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ (2000) Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95:261-266 (Pubitemid 30045651)
11. Sulak P, Willis S, Kuehl T, Coffee A, Clark J (2007) Headaches and oral contraceptives: Impact of eliminating the standard 7-day placebo interval. Headache 47:27-37 (Pubitemid 46096054)
12. Allais G, Bussone G, Airola G, Borgogno P, Castagnoli Gabellari I, de Lorenzo C, Pavia E, Benedetto C (2008) Oral contraceptiveinduced menstrual migraine. Clinical aspects and response to frovatriptan. Neurol Sci 29(Suppl 1):S186-S190 (Pubitemid 351836998)
13. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67:2154-2158 (Pubitemid 46035468)
14. Silberstein SD (1992) Menstrual migraine. Headache 32:312-313
15. Brandes JL (2006) The influence of estrogen on migraine: A systematic review. JAMA 295:1824-1830
16. Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24(Suppl.1):1-160
17. Sulak PJ, Kuehl TJ, Ortiz M, Shull BL (2002) Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 186:1142-1149 (Pubitemid 34665050)
18. Sulak PJ (2008) Continuous oral contraception: Changing times. Best Pract Res Clin Obstet Gynaecol 22(2):355-374 (Pubitemid 351305699)
19. Klipping D, Duijkers I, Trummer D, Marr J (2008) Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception 78(1):16-25
20. Sullivan H, Furniss H, Spona J, Elstein M (1999) Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 lg) and ethinyl estradiol (15 lg) on ovarian activity. Fertil Steril 72(1):115-120 (Pubitemid 29300271)
21. Nakajima ST, Archer DF, Ellman H (2007) Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 lg (Loestrin-24 Fe). Contraception 75:16-22 (Pubitemid 44854856)
22. Poindexter A, Reape KZ, Hait H (2008) Efficacy and safety of a 28-day oral contraceptive with 7 days of low dose estrogen in place of placebo. Contraception 78:113-119
23. Rice CF, Killick SR, Dieben T, Coelingh Bennink H (1999) A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily. Hum Reprod 14:982-985 (Pubitemid 29176478)
24. Grimes DA, Lopez LM, O'Brien PA, Raymond EG (2010) Progestin-only pills for contraception. Cochrane Database Syst Rev (1):CD007541
25. Ahrendt HJ, Karckt U, Pichl T, Mueller T, Ernst U (2007) The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results form two studies on oestrogen-related symptoms and dysmenorrhea. Eur J Contracept Reprod Health Care 12:354-361 (Pubitemid 350146719)
26. Ahrendt HJ, Kleinschmidt S, Kropf S et al (2007) Präventive Wirkung hormoneller Kontrazeptiva im Langzyklus bei menstrueller Migräne. Frauenarzt 48:2-7
27. World Health Organization (2004) Family and Reproductive Health Programme. Improving access to quality care in family planning: Medical eligibility criteria for contraceptive use, 3rd edn. World Health Organization Geneva, Switzerland
28. ACOG Committee on Practice Bulletins-Gynecology (2006) ACOG practice bulletin. No73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 107:1453-1472
29. Faculty of Sexual and Reproductive Health Care (2009) UK medical eligibility criteria for contraceptive use (UKMEC 2009). Published by the Faculty of Sexual and Reproductive Health Care-Royal College of Obstetricians and Gynaecologists. Available at http://ffprhc.org.uk/admin/uploads/UKMEC209.pdf
30. Nappi EW, Sances G, Allais G, Terreno E, Benedetto C, Vaccaro V, Polatti F, Facchinetti F (2011) Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: A prospective diary-based pilot study. Contraception 83(3):223-228